Larvol Delta - BioTheryX-Receives-IND-Clearance-from-FDA-to-Proceed-with-Phase-1-Study-of-BTX1188-a-Molecular-Glue-for-the-Treatment-of-Hematologic-and-Solid-Malignancies

BTX-1188 - BioTheryX

https://www.prnewswire.com/news-releases/biotheryx-receives-ind-clearance-from-fda-to-proceed-with-phase-1-study-of-btx-1188-a-molecular-glue-for-the-treatment-of-hematologic-and-solid-malignancies-301413819.html

Nov 2, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next